logo
logo

Avistone Acquires Courtyard Dulles Airport Herndon And Names Youngbin Park Vice President, Lodging Investments

Jun 15, 2022•about 3 years ago

Acquiring Company

Avistone Biotechnology Co., Inc

Acquired Company

Courtyard Dulles Airport Herndon

BeijingBiotechnology Research

Description

Officials of Avistone today announced the company acquired the 187-room Courtyard Dulles Airport Herndon in Va. The company also named Youngbin Park vice president, lodging investments.

Company Information

Company

Avistone Biotechnology Co., Inc

Location

Beijing, Beijing, China

About

Avistone is an oncology company focused on developing innovative therapies for patients with significant unmet medical needs globally. Avistone has an extensive pipeline of targeted therapies including two clinical-stage drug candidates and several ongoing programs in the pre-clinical development stage. The Company’s lead asset is PLB1001, a small-molecule inhibitor that targets MET tyrosine kinase activity, including aberrant activity observed with METexon14 skipping (genetic) alterations in NSCLC tumors and in other solid tumors. The company's second clinical asset is PLB1004, a potent inhibitor of EGFR tyrosine kinases (TKI), including aberrant activity observed with EGFR exon20 insertion (genetic) mutations in NSCLC tumors.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

David hidden

hidden

Brendan hidden

hidden